Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Selenium level and depressive symptoms in a rural elderly Chinese cohort
2012
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
2014
Proteomics-based Identification of Novel Factor Inhibiting Hypoxia-inducible Factor (FIH) Substrates Indicates Widespread Asparaginyl Hydroxylation of Ankyrin Repeat Domain-containing Proteins
2008 StandoutNobel
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies
2010
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Smad transcription factors
2005 Standout
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
2016
Telomerase inhibitors for the treatment of cancer: the current perspective
2001
Pharmacokinetics of pioglitazone after multiple oral dose administration in horses
2011
Anti-cancer potential of flavonoids: recent trends and future perspectives
2013
The effect of oral metformin on insulin sensitivity in insulin-resistant ponies
2011
The zebrafish as a vertebrate model of functional aging and very gradual senescence
2003
Impact of Selenium on Mood and Quality of Life: A Randomized, Controlled Trial
2005
Oncogenes as Novel Targets for Cancer Therapy (Part IV)
2005
Metallothionein Is a Potential Negative Regulator of Apoptosis
2003
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
2011 Standout
Selenium and human health
2012 Standout
c-Myc as a therapeutic target in cancer
2004
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Volume Progression in Autosomal Dominant Polycystic Kidney Disease
2005
Natural and pharmacological regulation of telomerase
2002
Cancer nanotechnology: opportunities and challenges
2005 Standout
Effects of the Insulin‐Sensitizing Drug Pioglitazone and Lipopolysaccharide Administration on Insulin Sensitivity in Horses
2011
Aptamers as therapeutics
2010 Standout
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food
2004 Standout
Iron oxide MR contrast agents for molecular and cellular imaging
2004 Standout
Equine Metabolic Syndrome
2010 Standout
The behaviour and ecology of the zebrafish,Danio rerio
2007 Standout
Cancer therapeutics: Targeting the dark side of Myc
2005
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
The future of antisense therapy: combination with anticancer treatments
2003
Reflecting on 25 years with MYC
2008 Standout
Equine Metabolic Syndrome
2011
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Molecular and cellular mechanisms of cadmium carcinogenesis
2003 Standout
Aflatoxin: A 50-Year Odyssey of Mechanistic and Translational Toxicology
2010
Natural compounds for cancer treatment and prevention
2009 Standout
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
The Myc oncoprotein as a therapeutic target for human cancer
2006
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Inhibition of Telomerase Activity by a Hammerhead Ribozyme Targeting the RNA Component of Telomerase in Human Melanoma Cells
2000
Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide
2002
Toxicology of antisense therapeutics
2004
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity
2003
mRNA Cancer Vaccines
2016
Matrix metalloproteinases and tumor metastasis
2006 Standout
Oncogenes as Novel Targets for Cancer Therapy (Part III)
2005
Safety Pharmacology and Genotoxicity Evaluation of AVI-4658
2010
Novel Nanosensors for Rapid Analysis of Telomerase Activity
2004
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
VITAMIN E, OXIDATIVE STRESS, AND INFLAMMATION
2005
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
2004 StandoutNobel
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Expression and regulation of brain metallothionein
1995
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Hypoxia Extends the Life Span of Vascular Smooth Muscle Cells through Telomerase Activation
2001
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Smad1, β-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription
2004
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Fluorescent Sensors for Zn2+Based on a Fluorescein Platform: Synthesis, Properties and Intracellular Distribution
2001 StandoutNobel
Reduction of aflatoxin level in aflatoxin-induced rats by the activity of probioticLactobacillus caseistrain Shirota
2013
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
2005 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Works of John E. Mata being referenced
Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B1 Pharmacokinetics in Human Volunteers
2009
Pharmacokinetics and In Vivo Effects of a Six-Base Phosphorothioate Oligodeoxynucleotide with Anticancer and Hematopoietic Activities in Swine
2000
Re-evaluation of the relative potency of synthetic and natural α-tocopherol: experimental and clinical observations
2004
Synthetic Antisense Oligonucleotide Probes the Essentiality of Metallothionein Gene
1992
Pharmacokinetics and bioavailability of metformin in horses
2009
Effects of chlorophyllin on transport of dibenzo(a, l)pyrene, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine, and aflatoxin B1 across Caco-2 cell monolayers
2004
Bolus Intravenous Injection of Phosphorothioate Oligonucleotides Causes Hypotension by Acting as α1-Adrenergic Receptor Antagonists
1999
Tumor cell growth is inhibited by suppressing metallothionein-I synthesis
1997
The Cytotoxic Effects of Single-Stranded Telomere Mimics on OMA-BL1 Cells
1999
c-myc antisense oligonucleotide treatment ameliorates murine ARPKD
2002
Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide Treatment
2000
Plant polyphenols and multidrug resistance: Effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models
2006
Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model
2003
In vivo growth inhibition of leukemia P388 by Metallothionein-I antisense oligodeoxyribonucleotide
1998
A Hexameric Phosphorothioate Oligonucleotide Telomerase Inhibitor Arrests Growth of Burkitt's Lymphoma Cellsin Vitroandin Vivo
1997